Medicine and Dentistry
Histone
100%
Cancer Therapy
100%
Fibrinogen
100%
PARP1
66%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
55%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 2
44%
Anemia
33%
Radiation Therapy
33%
Serine
22%
Hematopoiesis
22%
Adenosine Diphosphate Ribose
22%
DNA Damage Response
22%
Reactive Oxygen Species
11%
Side Effect
11%
Cisplatin
11%
Protein Binding
11%
Erythropoiesis
11%
Acute Myelogenous Leukemia
11%
Combination Therapy
11%
Bone Marrow Toxicity
11%
BRCA1
11%
Aspartic Acid
11%
Poly(adenosine Diphosphate Ribose)
11%
Glutamine
11%
Maintenance Therapy
11%
DNA Damage
11%
Myelodysplastic Syndrome
11%
Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Fibrinogen
100%
Histone
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
55%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 2
44%
Anemia
33%
Adenosine Diphosphate Ribose
22%
Knockout Mouse
22%
Serine
22%
Aspartic Acid
11%
Combination Therapy
11%
Poly(adenosine Diphosphate Ribose)
11%
Binding Protein
11%
Reactive Oxygen Metabolite
11%
Side Effect
11%
Cisplatin
11%
Glutamine
11%
Bone Marrow Toxicity
11%
Myelodysplastic Syndrome
11%
Biochemistry, Genetics and Molecular Biology
Histone
100%
Fibrinogen
100%
PolyADP-Ribosylation
100%
PARP1
63%
Poly ADP Ribose Polymerase
36%
Adenosine Diphosphate Ribose
27%
Hematopoiesis
18%
DNA Damage Response
18%
Knockout Mouse
18%
PARP2
18%
Serine
18%
Erythropoiesis
9%
Glutamine
9%
BRCA1
9%
Binding Protein
9%
DNA Damage
9%
Cisplatin
9%
Aspartic Acid
9%